Fahamka xidhiidhka ka dhexeeya MRD iyo CAR T-Cell therapy
Waa maxay MRD daawaynta kansarka? Cudurka haraaga ah ee la qiyaasi karo, ama MRD, waa magaca unugyada kansarka ee aadka u yar ee ku sii jira jirka ka dib ama inta lagu jiro daaweynta. Sitometry socodka, falcelinta silsiladda polymerase (PCR), ama jiilka xiga.
Daaweynta unugyada asliga ee mesenchymal ee xanuunada neerfaha
Cudurrada neerfaha waa dhibaatooyin waaweyn oo adduunka oo dhan ah sababtoo ah waxay keenaan dhimasho iyo naafo badan. Daawaynta dhaqameed had iyo jeer ma shaqayn, taas oo keentay isbeddel ku wajahan hababka cusub sida daawaynta unugyada ku salaysan. Beca..
Magacaabista daawada agoonta waxaa FDA siisay CART T-Cell Therapy A2B530 si loogu daweeyo kansarka mindhicirka
Bishii Maarso 2024, war-saxaafadeed ayaa sheegay in A2B530 (A2 Biotherapeutics), oo ah CAR T-cell therapy, la siiyay Magacaabista Dawooyinka Agoonta si loogu daweeyo kansarka mindhicirka kaasoo muujiya antigen-ka carcinoembryonic (CEA) oo ay lumisay HLA-A*02 expr.
Iovance's Amtagvi waxa ansixisay USFDA sida daawaynta ugu horraysa ee T-cell ee buro adag
Iovance Biotherapeutics 'immunotherapy-ga ugu horreeya ee nooceeda ah waxaa ansixiyay FDA. Tani waxay ka dhigan tahay in daawaynta T-cell, oo beddeshay habka loo daweeyo noocyada kansarka dhiigga qaarkood, hadda si toos ah loogu isticmaali karo burooyinka adag.
Amivantamab-vmjw waxa u ansixisay USFDA ee EGFR exon 20 galinta-is-beddelay calaamadaha kansarka sanbabada unugyada yaryar
Maamulka Cuntada iyo Dawooyinka ayaa ansixiyay amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) oo ay weheliso carboplatin iyo pemetrexed March 1, 2024. Bukaanka qaba receptor factor koritaanka epidermal (EGFR) exon 20 intio.
Osimertinib oo leh kiimoterabi waxaa u oggolaatay USFDA kansarka sanbabada unugyada aan-yarayn ee EGFR
Maamulka Cuntada iyo Dawooyinka ayaa ansixiyay osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP) oo ay weheliso kiimiko ku salaysan platinum oo loogu talagalay bukaannada qaba kansarka sambabada unugyada yaryar ee aan-yareyn ama metastatic (la/mNSC.)
Lifileucel waxa ay USFDA u ogolaatay melanoma aan la sixi karin ama metastatic
Maamulka Cuntada iyo Dawooyinka ayaa oggolaaday dardargelinta lifileucel (Amtagvi, Iovance Biotherapeutics, Inc.) Febraayo 16, 2024. Oggolaanshahan waxaa loogu talagalay bukaannada qaangaarka ah ee leh melanoma aan la daweyn karin ama metastatic melanoma ah kuwaas oo ...
Tepotinib waxa ay USFDA u ansixisay kansarka sambabada ee unugyada aan yarayn
Maamulka Cuntada iyo Dawooyinka ayaa si rasmi ah u ansixiyay tepotinib (Tepmetko, EMD Serono, Inc.) Febraayo 15, 2024, loogu talagalay bukaannada qaangaarka ah ee qaba kansarka sambabada unugyada unugyada yaryar (NSCLC) ee lahaa kala-guurka mesenchymal-epithelial (M..
Irinotecan liposome waxa u ansixisay USFDA daawaynta safka kowaad ee adenocarcinoma pancreatic.
Maamulka Cunnada iyo Dawooyinka ayaa ansixiyay irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) oo leh oxaliplatin, fluorouracil, iyo leucovorin Febraayo 13, 2024, si loogu daweeyo adenocarcinoma pancreatic metastatic sida…
Erdafitinib waxa u ansixisay USFDA kansarka urothelial urothelial ka horumaray ama metastatic
Erdafitinib (Balversa, Janssen Biotech) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka Janaayo 19, 2024, loogu talagalay bukaannada qaangaarka ah ee leh isbeddellada hidde-sideyaasha FGFR3 kuwaas oo gudaha u horumaray ama kansarka urothelial metastatic (mUC). Bukaan